Post-pandemic Era - Global Glaucoma Therapeutics Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Publisher Name :
Date: 12-Apr-2021
No. of pages: 105

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global Glaucoma Therapeutics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Glaucoma Therapeutics Market by XYZResearch Include

- China

- EU

- North America

- Japan

- India

- Southeast Asia

- South America

- Middle East and Africa

Competitive Analysis; Who are the Major Players in Glaucoma Therapeutics Market?

- Allergan

- Merck

- Novartis

- Pfizer

- Santen Pharmaceuticals

- Valeant Pharmaceuticals

- Aerie Pharmaceuticals

Major Type of Glaucoma Therapeutics Covered in XYZResearch report:

- Prostaglandins

- Alpha Agonist

- Beta Blockers

- Carbonic Anhydrase Inhibitor

- Cholinergic

- Combined Medication

Application Segments Covered in XYZResearch Market

- Hospitals

- Ophthalmic Clinics

- Ambulatory Surgical Centers

For any other requirements, please feel free to contact us and we will provide you customized report.

Post-pandemic Era - Global Glaucoma Therapeutics Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Table of Contents

Global Glaucoma Therapeutics Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Prostaglandins -Product Introduction and Major Manufacturers
1.1.2 Alpha Agonist -Product Introduction and Major Manufacturers
1.1.3 Beta Blockers -Product Introduction and Major Manufacturers
1.1.4 Carbonic Anhydrase Inhibitor -Product Introduction and Major Manufacturers
1.1.5 Cholinergic -Product Introduction and Major Manufacturers
1.1.6 Combined Medication -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Glaucoma Therapeutics Status and Prospect (2016-2027)
2.1.1 China Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.1.2 China Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Glaucoma Therapeutics Status and Prospect (2016-2027)
2.2.1 EU Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.2.2 EU Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Glaucoma Therapeutics Status and Prospect (2016-2027)
2.3.1 USA Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.3.2 USA Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Glaucoma Therapeutics Status and Prospect (2016-2027)
2.4.1 Japan Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.4.2 Japan Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Glaucoma Therapeutics Status and Prospect (2016-2027)
2.5.1 India Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.5.2 India Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Glaucoma Therapeutics Status and Prospect (2016-2027)
2.6.1 Southeast Asia Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.6.2 Southeast Asia Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Glaucoma Therapeutics Status and Prospect (2016-2027)
2.7.1 South America Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.7.2 South America Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Glaucoma Therapeutics Status and Prospect (2016-2027)
2.8.1 Glaucoma Therapeutics Market Size and Growth Rate (2016-2027)
2.8.2 Glaucoma Therapeutics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Glaucoma Therapeutics Market Assessment by Segment
3.1 Global Glaucoma Therapeutics Capacity and Growth Rate
3.2 Global Glaucoma Therapeutics Sales by Type
3.3 Global Glaucoma Therapeutics Sales Revenue by Type
3.4 Global Glaucoma Therapeutics Consumption by Application
4 Global Glaucoma Therapeutics Market Assessment by Regions
4.1 Global Glaucoma Therapeutics Production Analysis and Forecast by Regions (2016-2027)
4.2 Global Glaucoma Therapeutics Sales Analysis and Forecast by Regions (2016-2027)
4.3 Global Glaucoma Therapeutics Sales Revenue Analysis and Forecast by Regions (2016-2027)
5 Value Chain (Impact of COVID-19)
5.1 Glaucoma Therapeutics Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Glaucoma Therapeutics Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Glaucoma Therapeutics Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Glaucoma Therapeutics Sales Market Share of Manufacturers (2019-2020)
6.3 Global Glaucoma Therapeutics Sales Revenue Market Share of Manufacturers (2019-2020)
7 Glaucoma Therapeutics Competitive Analysis
7.1 Allergan
7.1.1 Allergan Company Profiles
7.1.2 Allergan Product Introduction
7.1.3 Allergan Glaucoma Therapeutics Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Merck
7.2.1 Merck Company Profiles
7.2.2 Merck Product Introduction
7.2.3 Merck Glaucoma Therapeutics Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Novartis
7.3.1 Novartis Company Profiles
7.3.2 Novartis Product Introduction
7.3.3 Novartis Glaucoma Therapeutics Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Pfizer
7.4.1 Pfizer Company Profiles
7.4.2 Pfizer Product Introduction
7.4.3 Pfizer Glaucoma Therapeutics Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Santen Pharmaceuticals
7.5.1 Santen Pharmaceuticals Company Profiles
7.5.2 Santen Pharmaceuticals Product Introduction
7.5.3 Santen Pharmaceuticals Glaucoma Therapeutics Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Valeant Pharmaceuticals
7.6.1 Valeant Pharmaceuticals Company Profiles
7.6.2 Valeant Pharmaceuticals Product Introduction
7.6.3 Valeant Pharmaceuticals Glaucoma Therapeutics Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Aerie Pharmaceuticals
7.7.1 Aerie Pharmaceuticals Company Profiles
7.7.2 Aerie Pharmaceuticals Product Introduction
7.7.3 Aerie Pharmaceuticals Glaucoma Therapeutics Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 ...
7.8.1 ... Company Profiles
7.8.2 ... Product Introduction
7.8.3 ... Glaucoma Therapeutics Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
8 Conclusion

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Glaucoma Therapeutics Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Glaucoma Therapeutics Sales (K Unit) by Type (2015-2026)
Figure Global Glaucoma Therapeutics Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Glaucoma Therapeutics Sales Market Share (%) by Type (2019 -2020)
Table Global Glaucoma Therapeutics Sales Value (Million USD) by Type (2015-2026)
Figure Global Glaucoma Therapeutics Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Glaucoma Therapeutics Sales Value Market Share (%) by Type (2019-2020)
Table Global Glaucoma Therapeutics Sales (K Unit) by Application (2015-2026)
Figure China Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table China Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table India Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Glaucoma Therapeutics Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Glaucoma Therapeutics Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Glaucoma Therapeutics Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Glaucoma Therapeutics Capacity (K Units) and Growth Rate (2015-2026)
Table Global Glaucoma Therapeutics Sales (Unit) by Type (2015-2026)
Figure Global Glaucoma Therapeutics Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Glaucoma Therapeutics Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Glaucoma Therapeutics Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Glaucoma Therapeutics Consumption (Unit) by Application (2015-2026)
Figure Global Glaucoma Therapeutics Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Glaucoma Therapeutics Production (K Unite) by Regions (2015-2020)
Table Global Glaucoma Therapeutics CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Glaucoma Therapeutics Production Share by Regions (2019-2020)
Table Global Glaucoma Therapeutics Sales (K Unite) by Regions (2015-2020)
Table Global Glaucoma Therapeutics CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Glaucoma Therapeutics Sales Share by Regions (2019-2020)
Table Global Glaucoma Therapeutics Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Glaucoma Therapeutics CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Glaucoma Therapeutics Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Glaucoma Therapeutics
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Glaucoma Therapeutics
Figure Cost Structure of Glaucoma Therapeutics in 2020
Table Global Glaucoma Therapeutics Capacity Share of Manufacturers (2019-2020)
Figure Global Glaucoma Therapeutics Capacity Share of Manufacturers (2019-2020)
Table Global Glaucoma Therapeutics Sales Market Share of Manufacturers (2019-2020)
Figure Global Glaucoma Therapeutics Sales Market Share of Manufacturers (2019-2020)
Table Global Glaucoma Therapeutics Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Glaucoma Therapeutics Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Glaucoma Therapeutics Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ?Allergan Profiles
Table ?Allergan Glaucoma Therapeutics Product Introduction
Table ?Allergan Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ?Allergan SWOT Analysis
Table Merck Profiles
Table Merck Glaucoma Therapeutics Product Introduction
Table Merck Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Merck SWOT Analysis
Table Novartis Profiles
Table Novartis Glaucoma Therapeutics Product Introduction
Table Novartis Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Novartis SWOT Analysis
Table Pfizer Profiles
Table Pfizer Glaucoma Therapeutics Product Introduction
Table Pfizer Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Pfizer SWOT Analysis
Table Santen Pharmaceuticals Profiles
Table Santen Pharmaceuticals Glaucoma Therapeutics Product Introduction
Table Santen Pharmaceuticals Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Santen Pharmaceuticals SWOT Analysis
Table Valeant Pharmaceuticals Profiles
Table Valeant Pharmaceuticals Glaucoma Therapeutics Product Introduction
Table Valeant Pharmaceuticals Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Valeant Pharmaceuticals SWOT Analysis
Table Aerie Pharmaceuticals Profiles
Table Aerie Pharmaceuticals Glaucoma Therapeutics Product Introduction
Table Aerie Pharmaceuticals Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Aerie Pharmaceuticals SWOT Analysis
Table ... Profiles
Table ... Glaucoma Therapeutics Product Introduction
Table ... Glaucoma Therapeutics Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ... SWOT Analysis

  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs